絞り込み

17876

広告

Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry.

著者 Salmon JH , Cacoub P , Combe B , Sibilia J , Pallot-Prades B , Fain O , Cantagrel A , Dougados M , Andres E , Meyer O , Carli P , Pertuiset E , Pane I , Maurier F , Ravaud P , Mariette X , Gottenberg JE
RMD Open.2015 ; 1(1):e000034.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (15view , 0users)
To evaluate the prevalence of late-onset neutropenia and its complications in patients treated with rituximab (RTX) for rheumatoid arthritis (RA) and other autoimmune diseases (AIDs) in a prospective registry.
PMID: 26509060 [PubMed]
印刷用ページを開く Endnote用テキストダウンロード